AI in Medical Writing Market – By Type, By Deployment Mode, By End-use, Forecast, 2024 – 2032

AI in Medical Writing Market Size

The global AI in medical writing market size was valued at USD 758.7 million in 2023 and is expected to exhibit growth at a CAGR of 13.1% from 2024 – 2032 period. The growth of AI in medical writing is attributed to greater emphasis on improving the process of medical writing, substantial increases in medical data for writing, and the development of intelligent generative AI software solutions
 

Also, the market is primarily driven by the progress of efficient and accurate clinical documentations. When dealing with huge quantities of data, traditional methods of medical writing are often difficult, labor-intensive and prone to errors. With the implementation of AI technologies such as NLP and machine learning algorithms, these complicated tasks are simplified, and human error has been greatly reduced. This improved accuracy is essential in regulated environments. As healthcare continues to grow, it is anticipated that there will be a high demand for AI solutions in medical writing during the forecast period.
 

Strict standards are applied to documents in clinical studies and submissions by regulatory bodies like EMA and FDA. AI technologies assist in the verification of medical documents with respect to the regulations by performing compliance checks and formatting control. Due to this requirement, the market players are also introducing intelligent solutions to accommodate the needs of writing standards. For instance, in June 2024, TrialAssure announced launch of TrialAssure LINK AI 2.0 medical writing software to assist pharmaceutical companies in regulatory writing. Such developments are expected to propel market growth.
 

AI in medical writing refers to applying AI technologies for automation and advanced authoring and management of medical documents, including clinical trial reports, regulatory submissions, and patient education materials.
 

AI in Medical Writing Market Trends

• Highly advanced machine learning models are now being integrated into the generation of documents which enables a much more complete comprehension and construction of intricate medical terminologies. These models are now able to read and draft documents with higher precision and more contextual depth.
   
• The data analytics field is benefiting significantly from the incorporation of AI-fueled analytics, which is translating to insightful and evidence-based medical writing. Another global trend is the ever-increasing application of AI in personalized medicine, where tailored patient educator materials and individual treatment plans are produced for each individual patient.
   
• Further, the increase of AI-powered, cloud-based healthcare solutions is another important trend, as it enables the wide-scale and flexible application of AI tools for different types of medical writing tasks. Therefore, these trends further improve the utility of AI in medical writing, making it an indispensable part of every healthcare facility’s documentation process.
   

AI in Medical Writing Market Analysis

Based on type, the market is classified into clinical writing, scientific writing, regulatory writing, and patient documentation. The clinical writing segment generated the highest revenue of USD 285 million in 2023.
 

• Reports, documents, and protocols that need to be written to get approval for a new drug or a medical device and for the supervision of the device are done under the umbrella of clinical writing. Clinical trials produce the most complicated and bulk amounts of data, and accurate clinical data for the analysis should comply with regulatory requirements.
   
• As datasets and clinical trials become larger and more complicated, the need for documentation becomes more robust and reliable. Clinical AI writing software has advanced capabilities that enable it to work with large datasets, write according to regulations, and produce high-quality medical documents in record time.
   

Based on deployment mode, the AI in medical writing market is categorized into on-premises and cloud. The cloud-based segment generated the highest revenue of USD 445.3 million in 2023.
 

• The shift from on-premises systems to cloud-based solutions has its advantages, one of which is the resistance to changing demand. This is particularly useful in medical writing as the fluctuations in the volume of clinical documentation or regulatory submissions.  
   
• Apart from this, cloud-based platforms enable users to access any AI tool or data, which supports remote collaboration and facilitates global research efforts. Organizations save costs since infrastructure development is not required due to the nature of the service. With cloud services, organizations are charged based on their use. The immense cost savings and flexibility support cloud-based deployment for organizations, thereby augmenting the segmental growth.

Based on end-use, the AI in medical writing market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, medical device companies, and other end-users. The pharmaceutical and biotechnology companies segment dominated the market in 2023 and is anticipated to reach USD 319.6 million by the end of forecast period.
 

• Pharmaceutical and biotechnology companies hold a major market share in the AI-driven medical writing sector due to their extensive documentation needs in drug development and regulatory affairs. Majorly, these organizations collect a lot of information from clinical trials, preclinical research, and regulatory submissions, which require detailed documentation to substantiate their research and validation of the products.
   
• Furthermore, AI solutions offer medical decision-makers powerful insights and analytics, which increases the decision-making process and operational efficiency. All these validities reinforce the business AI's powerful influence and necessity among other players in the business, especially among the pharmaceutical and biotechnology companies which seem to dominate the market for AI in medical writing.

North America AI in medical writing market accounted for USD 282.6 million market revenue in 2023 and is anticipated to grow at CAGR of 12.4% between 2024 – 2032 period.
 

• The growth of the market in North America is facilitated by the developed healthcare system of the region along with the significant amount of technology turnover.
   
• Due to the country’s advanced level of innovation and technology in healthcare, the market in the U.S. is expanding significantly. The large number of clinical studies and regulatory documents accompanied by strict rules leads to an increased need for AI.
   
• The documentation and filing processes for country’s pharmaceutical and biotechnology companies heavily rely on AI technologies to enhance efficiency and guarantee compliance. In addition, the existence of AI technology giants and research institutions in the U.S. further enhances the adoption and improvement of AI in medical writing.
   

UK AI in medical writing market is projected to grow remarkably in the coming years.
 

• The UK is observing substantial expansion in the use of AI technologies for medical writing because of a well-established healthcare system and advancement in technology. The National Health Services (NHS) and other health-related institutions are using more and more AI-based technologies for clinical documentation and research activities.
   
• The country’s focus on improving patient outcomes through data-driven approaches and its support for innovation in healthcare technology further drives the demand for AI in medical writing. Also, the presence of leading pharmaceutical companies and research institutions in the UK supports the growth of this market segment.
   

Japan holds a dominant position in the Asia Pacific AI in medical writing market.
 

• The AI in medical writing industry is growing in Japan due to its robust AI and healthcare sectors. Japan practices advanced medicine and effective healthcare systems, which explains the use of AI technology in medical writing.
   
• Additionally, Japanese pharmaceutical and biotech companies are using AI to improve the efficiency and accuracy of their documentation and regulatory filing.
   
• The Government of Japan is taking steps to enhance digital health and AI in the healthcare systems, which results in higher use of AI in medical writing across the nation.
   

AI in Medical Writing Market Share

The market's AI for medical writing major players is touching new heights in technology development and product portfolio expansion. Companies such as IBM and NVIDIA are improving their AI-enabled services to meet the expectations of medical prospective writers and authors.
 

Other recent advancements are improvements of natural language processing algorithms and AI algorithms incorporated into cloud-based system technology, which increases the productivity and scalability of medical writing tasks. With these technologies in place, these companies will be some of the major contributors to the growth and development of the market.
 

AI in Medical Writing Market Companies

Prominent players operating in the AI in medical writing industry include:

• Artos
• Cactus Communications
• CureMetrix, Inc.
• Elsevier
• Epic Systems Corporation
• Freyr
• GENINVO
• GNS Healthcare, Inc.
• IBM Corporation
• NVIDIA Corporation
• Parexel International (MA) Corporation
• Pearson
• TrialAssure
• Trilogy Writing & Consulting GmbH  
• Yseop 
   
• Specializes in AI-driven regulatory submissions and medical document automation.
   
• Offers tailored solutions for life sciences and pharmaceutical industries.
   
• Focuses on compliance with global medical writing standards and guidelines.
   

AI in Medical Writing Industry News:

• In July 2024, Yseop and Cognizant entered into a strategic collaboration with an aim to leverage its medical writing functionalities through generative AI technology. By implementing this collaboration, the Copilot platform of Yseop will be transformed into advanced medical writing tool with superior productivity.
   
• In July 2024, Certara announced launch of its AI-powered medical writing platform, CoAuthor. The platform incorporates generative AI algorithm and has capabilities to provide domain specific information.
   

The AI in medical writing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Clinical writing
• Regulatory writing
• Patient documentation  
• Scientific writing

Market, By Deployment Mode

• Cloud-based
• On-premises

Market, By End Use

• Pharmaceutical and biotechnology companies
• Medical device companies
• Academic and research institutes
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa